Table 5: Comparison of the predictive power among phospho-Her2/neu, phospho-EGFR, and phospho-Her2/neu/phospho-EGFR
in breast cancer survival assessment on this study cohort (N=235). P value represents the statistical significance of the
improvement over the control analysis
| Analysis |
Age |
ER |
PR |
Her2/neu |
pHer2/neu |
EGFR |
pEGFR |
F-measure |
Improvement |
| 1 |
x |
x |
x |
|
|
|
|
0.514 |
|
| 2 |
x |
x |
x |
|
x |
|
|
0.554 |
p < 0.19 |
| 3 |
x |
x |
x |
|
|
|
x |
0.533 |
p < 0.34 |
| 4 |
x |
x |
x |
|
x |
|
x |
0.590 |
p < 0.05 |